Intrinsic Value

Xenon Pharmaceuticals Inc. (XENE)


+0.24 (+0.63%)

Enterprise Value -
Net Debt -46.81
Equity Value -
Shares Outstanding 60.54
Equity Value Per Share -

Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt